News archives

Home > News archives > The patent on our functional antibody against GPCR was registered in Europe.

The patent on our functional antibody against GPCR was registered in Europe.

Mar 8,2016 -- Updated 09:45 +0900 (GMT)

On January 7th, 2016, a substance patent on our functional antibody against EP4 receptor was registered.